Clinical highlights from the National Cancer Data Base, 2000

• Published in: CA: a cancer journal for clinicians 2000-05, Vol.50 (3), p.171-183
• Main Authors: Stewart, A. K, Bland, K. I, McGinnis, L. S., Jr, Morrow, M, Eyre, H. J
• Format: Article
• Language: English
• Subjects: Adult; Aged; Aged, 80 and over; Cancer; Carcinoma - epidemiology; Clinical outcomes; Demographics; Female; Head and Neck Neoplasms - epidemiology; Head and Neck Neoplasms - therapy; Humans; Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy; Leukemia, Lymphocytic, Chronic, B-Cell - epidemiology; Liver Neoplasms - epidemiology; Liver Neoplasms - therapy; Lung Neoplasms - epidemiology; Lung Neoplasms - therapy; Male; Medical research; Middle Aged; Neoplasms - epidemiology; Parathyroid Neoplasms - epidemiology; Parathyroid Neoplasms - therapy; Stomach Neoplasms - epidemiology; Survival Rate; Testicular Neoplasms - epidemiology; Testicular Neoplasms - therapy; United States - epidemiology; Vulvar Neoplasms - epidemiology; Vulvar Neoplasms - therapy
• ISSN: 0007-9235; 1542-4863
• DOI: 10.3322/canjclin.50.3.171

The National Cancer Data Base (NCDB) is the empirical data collection and analysis arm of the American College of Surgeons Commission on Cancer, and is supported in part by the American Cancer Society. The NCDB collects oncology patient demographic information, diagnostic and treatment information, and outcomes data from a broad spectrum of hospital‐based cancer registries throughout the US, ranging from large research and teaching facilities to small community hospitals. Through this unique network, data are aggregated and reported back to participating hospitals to allow individual facilities to evaluate local patient care practices and outcomes. This article highlights the principal findings of articles published in 1999 and early 2000 that used NCDB data as the empirical basis of their analyses. Included among these are articles on breast cancer, gastric carcinoma, head and neck cancers, leukemia, liver carcinoma, lung cancer, parathyroid tumors, prostate carcinoma, small bowel adenocarcinoma, testicular malignancies, and vulvar melanoma. These articles are based on cases diagnosed between 1985 and 1996. The NCDB has accrued more than 6.4 million cancer cases for this time period. Sufficient numbers of rare cancers are reported to the NCDB to permit some types of clinical evaluation not possible using other data sources.